← back to search

Vivek Arora

Bristol-Myers Squibb (Germany) · GB
Area of research
Surgery · Molecular Biology
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Epigenetics and DNA Methylation, Prostate Cancer Treatment and Research, and Tissue Engineering and Regenerative Medicine.
h-index
26
citations
13,544
works
109
NIH funding
primary concept
email

Recent publications

KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
Cancer Research 2023cited by 50position: middledoi
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy
European Urology Oncology 2022cited by 11position: middledoi
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer
Cancer Medicine 2019cited by 26position: middledoi
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer
eLife 2017cited by 214position: middledoi
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Nature reviews. Cancer 2015cited by 1,527position: middledoi
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Cell 2014cited by 1,554position: middledoi
Aggressive Variants of Castration-Resistant Prostate Cancer
Clinical Cancer Research 2014cited by 425position: middledoi
Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade
Cell 2013cited by 992position: firstdoi
Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers
Cancer Discovery 2013cited by 563position: middledoi
Overcoming mutation-based resistance to antiandrogens with rational drug design
eLife 2013cited by 389position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Charles L. Sawyers · Molecular Oncology (United States)5 papers (2013–2017)John Wongvipat · Memorial Sloan Kettering Cancer Center4 papers (2013–2017)Philip A. Watson · University of Idaho3 papers (2013–2015)Neel Shah · AstraZeneca (United Kingdom)3 papers (2013–2017)Deyou Zheng · Albert Einstein College of Medicine3 papers (2013–2017)Hiram A. Gay · Northwell Health2 papers (2019–2022)Benjamin W. Fischer‐Valuck · Radiant Research (United States)2 papers (2019–2022)Minna Balbas · Roswell Park Comprehensive Cancer Center2 papers (2013–2013)Yu Chen · Guangdong Academy of Medical Sciences2 papers (2013–2013)Eric H. Kim · University of Nevada, Reno2 papers (2019–2022)Ruben Carmona · University of Miami2 papers (2019–2022)Ling Cai · Duke University2 papers (2013–2013)John P. Christodouleas · UPMC Hillman Cancer Center2 papers (2019–2022)Bruce J. Roth · Washington University in St. Louis2 papers (2019–2022) · 2 papers (2019–2022)Mohamed S. Zaghloul · National Heart Institute2 papers (2019–2022) · 1 papers (2023–2023)Bing Ren · Hebei University of Engineering1 papers (2023–2023) · 1 papers (2023–2023)Daniel E. Spratt · Drexel University1 papers (2013–2013)